BDBM524432 N-((S)-3-(1H-imidazol-4-yl)-1- (methylamino)-1-oxopropan-2-yl)-2- ((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)thiazole-4- carboxamide::US11168083, Example 30

SMILES CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1

InChI Key InChIKey=YZUIZAHXHMYKIB-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 524432   

TargetPlasma kallikrein(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM524432(N-((S)-3-(1H-imidazol-4-yl)-1- (methylamino)-1-oxo...)
Affinity DataEC50: >9.90E+3nMAssay Description:Plasma Kallikrein: The example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
Go to US Patent